Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Autologous Stem Cell Transplantation Is Effective in Chemosensitive HIV-Associated Lymphoma Irrespective of Previous Therapy and Histological Subtype

Alessandro Re, MD, Nicola Bianchetti, Chiara Cattaneo, MD, Salvatore Casari, MD, Chiara Pagani, MD, Annalisa Peli, MD, Emanuele Focà, MD, Pierino ferremi Leali, MD, Camillo Almici, MD, Francesco Castelli, MD, Giuseppe Rossi

Blood (2018) 132 (Supplement 1): 2145.

https://doi.org/10.1182/blood-2018-99-116816

Published: 2018

Journal Articles

Aids Related Primary Central Nervous System Lymphoma Is Still a Challenge in the Cart Era: A Single Centre Experience

Alessandro Re, MD, Chiara Cattaneo, MD, Salvatore Casari, MD, Annalisa Peli, MD, Nicola Bianchetti, MD, Angela Passi, MD, Emanuele Focà, MD, Maria Miscio, Francesco Castelli, MD, Giuseppe Rossi, MD

Blood (2017) 130 (Supplement 1): 5223.

https://doi.org/10.1182/blood.V130.Suppl_1.5223.5223

Published: 2017

Journal Articles

Early Consolidation with High Dose Therapy and Autologous Stem Cell Transplantation in HIV-Associated Non Hodgkin Lymphoma at High Risk (aa-IPI 2-3). Mature Results of a Multicenter Prospective Phase II Trial

Alessandro Re, MD, Chiara Cattaneo, MD, Salvatore Casari, MD, Guido Gini, MD, Mariagrazia Michieli, Bernardino Allione, Luisa Verga, MD, Caterina Bocci, Michele Spina, MD, Stefania Tamiazzo, Alessandra Bandera, Flavia Salvi, MD, Annalisa Peli, MD, Moira Micheletti, Camillo Almici, MD, Pierino Ferremi, Umberto Tirelli, MD, Giuseppe Rossi, MD

Blood (2014) 124 (21): 2528.

https://doi.org/10.1182/blood.V124.21.2528.2528

Published: 2014

Journal Articles

Early Consolidation with High Dose Therapy and Autologous Stem Cell Transplantation in HIV-Associated Non Hodgkin Lymphoma At High Risk (Aaipi 2–3). an Interim Report of a Multicenter Phase II Trial.

Alessandro Re, MD, Mariagrazia Michieli, Bernardino Allione, MD, Salvatore Casari, MD, Chiara Cattaneo, MD, Michele Spina, Andrea Gori, Elisa Garlassi, Luisa Verga, MD, Camillo Almici, MD, Pierino Ferremi, Mario Mazzucato, Alessandro Levis, MD, Umberto Tirelli, MD, Giuseppe Rossi, MD

Blood (2012) 120 (21): 3124.

https://doi.org/10.1182/blood.V120.21.3124.3124

Published: 2012

Journal Articles

Plasmablastic Lymphoma Among HIV-Positive Patients: A Curable Entity? Results of a Single Centre's Experience

Chiara Cattaneo, MD, Alessandro Re, MD, Annalisa Peli, MD, Salvatore Casari, MD, Stefano Fogazzi, MD, Francesca Antoniazzi, MD, Chiara Pagani, MD, Francesca Schieppati, MD, Alfredo Scalzini, MD, Francesco Castelli, MD, Giuseppe Rossi

Blood (2012) 120 (21): 3640.

https://doi.org/10.1182/blood.V120.21.3640.3640

Published: 2012

Journal Articles

Treating Hodgkin Lymphoma in HIV Positive Patients: a Comparative Analysis with the HIV Negative Population.

Alessandro Re, MD, Chiara Cattaneo, MD, Salvatore Casari, MD, Samantha Ferrari, MD, Elisa Cerqui, MD, Graziella Cristini, MD, Giampiero Carosi, MD, Giuseppe Rossi, MD

Blood (2009) 114 (22): 3711.

https://doi.org/10.1182/blood.V114.22.3711.3711

Published: 2009

Journal Articles

A 3-Year Prospective Surveillance Study of Microbiological Isolates among Hematologic Inpatients Shows a High Frequency of Both Community-Acquired and Nosocomial Methicillin-Resistant (MR) and Fluoroquinolone-Resistant (FqR) Strains and the Recent Increase of Enterococci, Viridans Streptococci and Pseudomonaceae with Frequent Antibiotic Multiresistance.

Chiara Cattaneo, MD, Salvatore Casari, MD, Erika Borlenghi, MD, Maria Adele Capucci, MD, Moira Micheletti, MD, Alessandro Re, MD, Giampiero Carosi, MD, Giuseppe Rossi, MD

Blood (2007) 110 (11): 2286.

https://doi.org/10.1182/blood.V110.11.2286.2286

Published: 2007

Journal Articles

High Dose Therapy and Autologous Peripheral Blood Stem Cell Transplantation as Salvage Therapy for HIV-Associated Lymphoma: Result of the GICAT Study.

Alessandro Re, MD, Mariagrazia Michieli, MD, Chiara Cattaneo, MD, Maurizio Rupolo, MD, Salvatore Casari, MD, Michele Spina, MD, Bernardino Allione, MD, Camillo Almici, MD, Piero Ferremi, MD, Luciano Abruzzese, MD, Cecilia Simonelli, MD, Rosa Manuele, MD, Alessandro Levis, MD, Giampiero Carosi, MD, Umberto Tirelli, MD, Giuseppe Rossi, MD

Blood (2007) 110 (11): 23.

https://doi.org/10.1182/blood.V110.11.23.23

Published: 2007

Journal Articles

Ann Arbor Stage Is the Most Important Predictor of Survival for Refractory and Relapsed HIV-Associated Lymphoma Enrolled in a Program of High Dose Therapy and Autologous Peripheral Blood Stem Cell Transplantation.

Alessandro Re, MD, Chiara Cattaneo, MD, MariaGrazia Michieli, MD, Salvatore Casari, MD, Michele Spina, MD, Maurizio Rupolo, MD, Bernardino Allione, MD, Piero Ferremi, MD, Arnalda Lanfranchi, PhD, Mauro Mazzuccato, MD, Gianpiero Carosi, MD, Umberto Tirelli, MD, Giuseppe Rossi, MD

Blood (2004) 104 (11): 893.

https://doi.org/10.1182/blood.V104.11.893.893

Published: 2004

NARROW

Autologous Stem Cell Transplantation Is Effective in Chemosensitive HIV-Associated Lymphoma Irrespective of Previous Therapy and Histological Subtype

Aids Related Primary Central Nervous System Lymphoma Is Still a Challenge in the Cart Era: A Single Centre Experience

Early Consolidation with High Dose Therapy and Autologous Stem Cell Transplantation in HIV-Associated Non Hodgkin Lymphoma at High Risk (aa-IPI 2-3). Mature Results of a Multicenter Prospective Phase II Trial

Early Consolidation with High Dose Therapy and Autologous Stem Cell Transplantation in HIV-Associated Non Hodgkin Lymphoma At High Risk (Aaipi 2–3). an Interim Report of a Multicenter Phase II Trial.

Plasmablastic Lymphoma Among HIV-Positive Patients: A Curable Entity? Results of a Single Centre's Experience

Treating Hodgkin Lymphoma in HIV Positive Patients: a Comparative Analysis with the HIV Negative Population.

High Dose Therapy and Autologous Peripheral Blood Stem Cell Transplantation as Salvage Therapy for HIV-Associated Lymphoma: Result of the GICAT Study.

Ann Arbor Stage Is the Most Important Predictor of Survival for Refractory and Relapsed HIV-Associated Lymphoma Enrolled in a Program of High Dose Therapy and Autologous Peripheral Blood Stem Cell Transplantation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only